Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilal Eser-Ozturk

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Ocular Immunology and Inflammation|June 5, 2019
The Results of Interferon-Alpha Treatment in Behçet UveitisHilal Eser-Ozturk, Yuksel Sullu
Ocular Immunology and Inflammation|May 29, 2020
Pediatric Uveitis in a Referral Center in North Part of TurkeyHilal Eser-Ozturk, Yuksel Sullu
Arquivos Brasileiros De Oftalmologia|September 28, 2022
Retinal thickness profiles in patients with Behçet uveitis during remissionIdil Farisogullari, Hilal Eser-Ozturk
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|December 10, 2025
Monitoring Behçet uveitisHilal Eser-Ozturk, Ilknur Tugal-Tutkun
Eye & Contact Lens|May 31, 2013
Corneal sensitivity may decrease in adenoviral epidemic keratoconjunctivitis--a confocal microscopic studyHilal Eser Ozturk, Baris Sonmez, Umit Beden
Arquivos Brasileiros De Oftalmologia|February 7, 2019
Comparison of choroidal thickness in patients with active and stable thyroid eye diseaseAdem Gul, Ekrem Basural, Hilal Eser Ozturk
International Ophthalmology|May 16, 2020
Changes in corneal thickness, upper and lower tear film in seasonal allergic conjunctivitis by steroid treatment: anterior segment optical coherence tomography studyVolkan Yeter, Nurullah Koçak, Hilal Eser-Ozturk
Ocular Immunology and Inflammation|October 12, 2017
Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha TherapyHilal Eser Ozturk, Merih Oray, Ilknur Tugal-Tutkun
Ocular Immunology and Inflammation|April 1, 2025
Anti-Adalimumab Antibodies in Patients with Noninfectious Uveitis Who Use Adalimumab Weekly or Every Other WeekLeman Ismayilova, Hilal Eser-Ozturk, Asuman Birinci, et al.
Ocular Immunology and Inflammation|February 24, 2022
Sarcoid-like Uveitis with or without Tubulointerstitial Nephritis during COVID-19Hilal Eser-Ozturk, Tugba Izci Duran, Ozlem Aydog, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ocular Immunology and Inflammation|June 5, 2019
The Results of Interferon-Alpha Treatment in Behçet UveitisHilal Eser-Ozturk, Yuksel Sullu
Ocular Immunology and Inflammation|May 29, 2020
Pediatric Uveitis in a Referral Center in North Part of TurkeyHilal Eser-Ozturk, Yuksel Sullu
Arquivos Brasileiros De Oftalmologia|September 28, 2022
Retinal thickness profiles in patients with Behçet uveitis during remissionIdil Farisogullari, Hilal Eser-Ozturk
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|December 10, 2025
Monitoring Behçet uveitisHilal Eser-Ozturk, Ilknur Tugal-Tutkun
Eye & Contact Lens|May 31, 2013
Corneal sensitivity may decrease in adenoviral epidemic keratoconjunctivitis--a confocal microscopic studyHilal Eser Ozturk, Baris Sonmez, Umit Beden
Arquivos Brasileiros De Oftalmologia|February 7, 2019
Comparison of choroidal thickness in patients with active and stable thyroid eye diseaseAdem Gul, Ekrem Basural, Hilal Eser Ozturk
International Ophthalmology|May 16, 2020
Changes in corneal thickness, upper and lower tear film in seasonal allergic conjunctivitis by steroid treatment: anterior segment optical coherence tomography studyVolkan Yeter, Nurullah Koçak, Hilal Eser-Ozturk
Ocular Immunology and Inflammation|October 12, 2017
Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha TherapyHilal Eser Ozturk, Merih Oray, Ilknur Tugal-Tutkun
Ocular Immunology and Inflammation|April 1, 2025
Anti-Adalimumab Antibodies in Patients with Noninfectious Uveitis Who Use Adalimumab Weekly or Every Other WeekLeman Ismayilova, Hilal Eser-Ozturk, Asuman Birinci, et al.
Ocular Immunology and Inflammation|February 24, 2022
Sarcoid-like Uveitis with or without Tubulointerstitial Nephritis during COVID-19Hilal Eser-Ozturk, Tugba Izci Duran, Ozlem Aydog, et al.
Pageof 2